Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
JNJ-7706621 shows inhibitory effect on a panel of human cancer cell types
Laropiprant
4)17(18)6-10-26(16
3-benzodiazole sodium
Clinical indications: Balanitis
Isavuconazole ndinavir sulfate JNJ-7706621 shows inhibitory effect onIsavuconazole, also knownc as BAL4815 and RO 0094815, is a triazole antifungal drug. Its prodrug, isavuconazonium sulfate (BAL8557), was granted approval by the U. S. Food and Drug Administration (FDA) on March 6, 2015 for the treatment of invasive candidiasis. Isavuconazole works by inhibiting lanosterol 14 alpha demethylase, the enzyme responsible for converting lanosterol to ergosterol by demethylation. The resulting depletion of ergosterol and
US$ 50.00
US$ 50.00
US$ 30.00
US$ 22.95
US$ 100.00
US$ 249.00
US$ 100.00
US$ 337.50
US$ 38.00
US$ 15.00
US$ 180.00
US$ 200.00
US$ 237.50
US$ 319.00